Ambrisentan and oedema peripheral Patient Reports February 11, 2012

Ambrisentan Side Effects Report #5803855-9
Ambrisentan side effect was reported by a Consumer or non-health professional from UNITED STATES on June 26, 2008. Female patient, weighting 250.0 lb, was diagnosed with pulmonary arterial hypertension, embolism, pulmonary hypertension , oedema and was treated with Ambrisentan. After drug was administered, patient experienced the following side effects: arthralgia, hepatic enzyme increased, international normalised ratio increased, oedema peripheral, pain in extremity, right ventricular failure. Ambrisentan dosage: unknown. During the same period patient was treated with COUMADIN, REVATIO, FUROSEMIDE, SPIRONOLACTONE, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE, ZAROXOLYN. Patient was hospitalized and became disabled. Patient recovered.

Ambrisentan Side Effects Report #5868256-6
Ambrisentan side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 25, 2008. Female patient, weighting 250.0 lb, was diagnosed with pulmonary arterial hypertension, embolism, pulmonary hypertension , oedema and was treated with Ambrisentan. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, arthralgia, aspartate aminotransferase increased, gouty tophus, hepatic congestion, hepatomegaly, international normalised ratio increased, oedema peripheral, pain in extremity. Ambrisentan dosage: unknown. During the same period patient was treated with COUMADIN, REVATIO, FUROSEMIDE, SPIRONOLACTONE, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE, ZAROXOLYN. Patient was hospitalized. Patient recovered.

Ambrisentan Side Effects Report #5950484-2
Ambrisentan side effect was reported by a Consumer or non-health professional from UNITED STATES on Oct 30, 2008. Female patient, weighting 250.0 lb, was diagnosed with pulmonary arterial hypertension, embolism, pulmonary hypertension , oedema and was treated with Ambrisentan. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, international normalised ratio increased, oedema peripheral, right ventricular failure. Ambrisentan dosage: unknown. During the same period patient was treated with COUMADIN, REVATIO, FUROSEMIDE, SPIRONOLACTONE, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE, ZAROXOLYN. Patient was hospitalized. Patient recovered.

Ambrisentan Side Effects Report #5964414-0
Ambrisentan side effect was reported by a Consumer or non-health professional from UNITED STATES on Nov 13, 2008. Female patient, weighting 250.0 lb, was diagnosed with pulmonary arterial hypertension, embolism, pulmonary hypertension , oedema and was treated with Ambrisentan. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, international normalised ratio increased, oedema peripheral, right ventricular failure. Ambrisentan dosage: unknown. During the same period patient was treated with COUMADIN, REVATIO, FUROSEMIDE, SPIRONOLACTONE, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE, ZAROXOLYN. Patient was hospitalized. Patient recovered.


Ambrisentan Side Effects Report #6016526-3
Ambrisentan side effect was reported by a Physician from GERMANY on Dec 10, 2008. Female patient, weighting 110.2 lb, was diagnosed with pulmonary arterial hypertension and was treated with Ambrisentan. After drug was administered, patient experienced the following side effects: dyspnoea, eyelid oedema, oedema peripheral. Ambrisentan dosage: unknown. During the same period patient was treated with REVATIO, LASIX. Patient recovered.